New lawsuits claim GLP-1 drugs led to vision loss

Dozens of lawsuits have been filed against the companies behind popular GLP-1 drugs Ozempic, Wegovy and Zepbound, claiming the drugs led to a rare type of vision loss.

ABC News’ Elizabeth Schulze reports.

Related posts

Leave a Comment